10.1523/jneurosci.1632-05.2005 J
Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor
Ingredients: Water, Butylene Glycol, Caprylic/Capric Triglyceride, Beeswax, Niacinamide, Cetearyl Alcohol, Isononyl Isononanoate, Arachidyl Alcohol, 1,2-Hexanediol, Polyglyceryl-3 Methylglucose Distearate, Behenyl Alcohol, Glyceryl Stearate, Betaine, Dimethyl-trimethylsilyloxysilane, Arachidyl Glucoside, Cetearyl Olivate, Arginine, Carbomer, Sorbitan Olivate, Allantoin, Glycerin, Panthenol, Tocopherol, Xanthan Gum, Glutathione(600 ppm), Dipotassium Glycyrrhizate, Ethylhexylglycerin, Disodium EDTA, Sodium Hyaluronate , Glucose, Alcohol, Malva Sylvestris (Mallow) Extract, Melissa Officinalis Leaf Extract, Alchemilla Vulgaris Extract, Achillea Millefolium Extract, Veronica Officinalis Extract, Mentha Piperita (Peppermint) Leaf Extract, Primula Veris Extract, Lycopodium Clavatum Extract, Equisetum Arvense Extract, Ceramide NP, Hydrogenated Lecithin, Polyglyceryl-10 Stearate, Sodium Hydroxide, Sodium Ascorbyl Phosphate, Biotin, Folic Acid, Pyridoxine, Cyanocobalamin, Linoleic Acid, Riboflavin, Beta-Carotene, Thiamine HCl, Copper Tripeptide-1, Acetyl Hexapeptide-8, Palmitoyl Pentapeptide-4, Palmitoyl Tetrapeptide-7, Palmitoyl Tripeptide-1, Fragrance
The resultant myocardial cell damage and electrophysiological alterations are strongly predisposed to triggering arrhythmias, particularly ventricular arrhythmias such as premature ventricular beats, ventricular tachycardia, and ventricular fibrillation
LeeMHongSChoYRheeHYuMHBaeJet al
